Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]

Clinical trial NCT00785954 · COMPLETED

Trial details

NCT number: NCT00785954
Sponsor: KAI Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myocardial Infarction Cardiovascular Diseases Pathologic Processes

Start date: 2008-11-01
Primary completion: 2010-07-01
Enrollment: 1180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.